Health ❯ Medical Research

Clinical Trials

Drug Development Gene Therapy Cancer Treatment Neuroscience Animal Studies Neurology Innovative Treatments Immunotherapy Drug Efficacy Spinal Cord Injury

Bayer to Acquire Perfuse Therapeutics for Up to $2.45 Billion to Bolster Eye Pipeline

The purchase secures PER-001 for Bayer, a Phase II eye implant that blocks endothelin to treat leading causes of vision loss.

Harvard Study Finds OpenAI’s o1 Model Outdiagnoses ER Physicians on Text-Only Cases

Frozen Childhood Testicular Tissue Reimplanted in First Human Case Produces Sperm

Doctors Outline Safe Use of Peptides as FDA Weighs Easing Restrictions

Sam Neill Says He Is Cancer-Free After CAR-T Therapy

PNAS Retracts Barbacid Pancreatic Cancer Mouse Study Over Undisclosed Conflicts

Pilot Blood-Filtering Device Shows Early Promise for Severe Preeclampsia

Lilly to Acquire Ajax Therapeutics in Up to $2.3 Billion Blood Cancer Deal

Intellia’s Gene-Editing Drug Cuts HAE Attacks 87% in Phase 3 as FDA Filing Begins

CAR-T Therapy Puts Three Autoimmune Diseases Into Sustained Remission in One Patient

AWS Launches Amazon Bio Discovery to Speed Early Drug Discovery

Allogene Soars on Early ALPHA3 Readout Showing Strong MRD Edge and Clean Safety

JW Pharmaceutical Licenses Korean Rights to Gan & Lee’s GLP-1 Drug in Deal Worth Up to $81 Million

Cornell Study Shows Reversible Male Contraception by Targeting Meiosis in Mice

Soleno Faces Securities Class Action Over DCCR Safety as Investors Weigh May 5 Lead‑Plaintiff Deadline

Antidepressant Fluvoxamine Eases Long COVID Fatigue in Randomized Trial

FDA Approves First Therapy for Acquired Hypothalamic Obesity, Expanding Rhythm’s Imcivree

Humacyte Raises $20 Million in Direct Offering and Lands Saudi Symvess Purchase Pact

Early Human Trial of Topical PP405 Reports Short-Term Hair Density Gains

Large Trial Finds No Acute COVID Benefit From Vitamin D, Hints at Fewer Long COVID Symptoms